Both companies are betting on interest in weight loss pills.

Men no longer view aesthetic treatments as vanity but as optimization, similar to fitness, grooming or skincare,” one ...

We decided to exit the Oracle position and book a short-term tax loss, spreading the capital across several of the ...

Novo and Lilly are locked in a tightening fight in the obesity-drug market, with Novo trying to win back its crown after a ...

New data shows Wegovy pill uptake: 36% are new to GLP-1s, with many switching from injectable versions. Read more here.

The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but recent challenges have centered around protecting its market share.

TrumpRx is a federal website offering prescription drug discounts, though some users may face hurdles to see a benefit.

Despite their huge popularity, GLP-1 injury lawsuits citing the drugs as a cause for a host of severe GI issues and even ...

Eli Lilly is priced for perfection thanks to its GLP-1 drugs, while Wall Street seems to have forgotten about these two ...

When Mike Doustdar started as a summer employee making copies at Novo Nordisk—a teenager living in Austria after fleeing unrest in his home country of Iran at 12—he never imagined he would remain at ...

Joe Budden discusses using Zepbound, fitness changes, and health awareness during an appearance on 'Club Shay Shay.' ...

Eli Lilly's fourth-quarter revenue rose by 43%, largely a result of its impressive GLP-1 products. Sales from its GLP-1 drugs ...